Congratulations Dr. Chan Lee Gaik and Hospital Umum Sarawak study team for recruiting the first subject in Malaysia for Peads Influenza study on 13 March and achieving extended recruitment target on 30 April.
Double joy for Hospital Miri!
We would like to congratulate Dato’ Dr. Fam Tem Lom and Dr. Louise Ngu, and their study team for being the first in Malaysia to recruit patients for Influenza A (on 15 March) & Peads RSV (on 7 May) study respectively.
We are truly proud of these achievements and hope for more great news from Hospital Miri.
The University of Malaya together with the Johns Hopkins Berman Institute of Bioethics have developed the Master of Health Research Ethics (MOHRE) Programme which is funded by the US National Institute of Health.
The development of this programme draws on the expertise of bioethicists and educationist from Johns Hopkins University and a multidisciplinary group of faculty members from UM in the field of medicine, law, and education. This one-year programme provides an excellent opportunity to learn about research ethical issues in the field of health and medicine through theories and practicum.
Graduates of the programme will have the opportunity to explore careers related to health research ethics such as research ethics committee member, university, academician or lecturer, a researcher in health institutions, manager of clinical research centers, an executive in ethics accreditation body and policy-makers in a government agency. Ten scholarships are provided for eligible candidates.
The application deadline is on 31 May every year.
KUALA LUMPUR, 25 April 2019 – We had the CRM Investigator Dialogue 2019, a platform to discuss relevant matters in conducting Sponsored Research.
We invited Ms Yam Pei Ching (NPRA), Dr Hjh Salina Abdul Aziz (MREC), Dr Hjh Rosaida Hj Md Said (Investigator, Hospital Ampang) and Ms SuLyn Yip (Novotech) to give a talk and updates on their respective areas.
Special thanks to Dato’ Dr Goh Pik Pin, Director of Clinical Research Centre Malaysia for her welcoming speech.
Last but not least, a big thank you to all investigators for your time and thoughts given for this year Investigator Dialogue.
Its the first CRM Industry Dialogue for 2019!
CRM Industry Dialogue provides an avenue for Pharmaceutical companies (sponsors) and CROs to directly convey any issues, suggestions or opinions that they may have to CRM. Besides strengthening cooperation and networking between all parties, CRM also takes the opportunity to update the clinical research industry on local laws, guidelines and regulations. By bringing together these industry players, CRM uses this platform to connect with them and provide upates on its current and future activities.
We would to thank our guest speakers Ms. Yip Su Lyn (Country Manager, Novotech), Dr. Zaril Harza bin Zakaria (Deputy Director, Centre for Investigational New Product, NPRA) and Dr. Hjh Salina Abdul Aziz (Chairperson, MREC) for sharing important updates with us today.
We invited Dr Hjh Salina Abd Aziz (Chairperson, MREC), Dr Zaril Harza Zakari (Deputy Director, NPRA), Puan Aidahwaty (Director Technical Evaluation, MDA), Mr Lau Thye Mun (Deputy Director, Royal Malaysian Customs Department) and Mr Ewe Kheng Huat (Executive Director, PhAMA) to have a dialogue session with the industry players.
Our humble gratitude to all.
ResMed changes lives with award-winning medical devices and cutting-edge cloud-based software applications that diagnose, treat and manage sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD) and other chronic respiratory diseases. ResMed is a global leader in connected care, with millions of patients remotely monitored every day. Our team is committed to creating the world’s best tech-driven medical device company – improving quality of life, reducing the impact of chronic disease, and saving healthcare costs in more than 100 countries. Read more
Congratulations to the Free Paper Presentation winners at the recent NHAM-CRM Research Track 2019!
Biomedical/Public Health/Clinical category: Winner: Ms Nor Firdous Mohamed (Universiti Pendidikan Sultan Idris) Title: “Development and Validation of a Coronary Heart Diseases Specific-Complementary Alternative Medicines Usage Questionnaire” 1st Runner Up: Dr Hanis Hidayu Kasim (Faculty of Medicine and Health Sciences, Universiti Sains Islam Malaysia) Title: “Is ABPM a Better Device for Monitoring Pregnancy than Sphygmomanometer?” 2nd Runner Up: Dr Ahmad Zaid Zainal (Hospital Kuala Lumpur) Title: “Analysis of Patients with Poor Ejection Fraction Demonstrated on Nitrates-Enhanced SPECT Rest- Only Imaging and Their Scintigraphy Findings”
Basic Science/Translational Research category: Winner: Dr Wan Amir Nizam (School of Health Sciences, Universiti Sains Malaysia) Title: “Vascular Endothelium Dysfunction in REM Sleep Deprivation: Prelude to Cardiovascular Disease”
ABOUT THE SPEAKERS
Assoc Prof Dr Siti Hamimah
Meet Assoc Prof Dr Siti Hamimah, Director of Institute of Medical Molecular Biotechnology at Faculty of Medicine, UiTM. She holds a PhD from Imperial College London where she studied how bile acid affects heart cells signaling and function at molecular level. After her PhD, she continues her work in understanding how the most hydrophilic bile acid, ursodeoxycholic acid protects cardiac cells against reactive oxygen species. Currently, she is interested on endocrine disruptor compounds (EDCs) and understanding how EDCs affect the normal programming heart cells.
Assistant Professor Dr. Lee Siew Keah
Meet Assistant Professor Dr. Lee Siew Keah, a faculty member of Faculty of Medicine and Health Sciences in Universiti Tunku Abdul Rahman, Malaysia. She obtained her Bachelor of Health Sciences (Biomedicine)(Hons) with the award of first-class honours in year 2006 and then her Ph.D degree in year 2011 in Universiti Sains Malaysia.
Her early research work focused the roles of genetic and environmental influences in prenatally programmed hypertension. She also explored the role of melatonin as a novel therapeutic agent in treating cardiovascular disease. In addition to publication in peer-reviewed journals, these research works earned three Anugerah Sanggar Sanjung Merit Awards from USM, Young Investigator Fellowship award from Asia Pacific Society of Hypertension, European Investigators Accommodation Grant from European Society of Hypertension as well as Travel Grant Award from International Society of Hypertension.
In recent years, she expanded her research into the impact of concurrent use of food/herbal medicine particularly tea catechins, and conventional medications especially anti-hypertensive drugs. She believes that her research would give valuable insights and awareness on the risk the therapeutic failure or toxicity effect among habitual tea consumers who are taking anti-hypertensive medication concurrently.
Siew-Keah believes that research and academic teaching are inseparable and synergistic. She believes that contributions and experience in teaching & learning activities, administrative responsibilities and in professional society are equally important, and she strives to be a well-rounded educator. She won two Congratulatory Awards for excellent teaching performance in year 2018. In addition to the extensive faculty administrative appointments, she has been actively involved in local and international professional societies.
Professor Chim Lang
Meet Professor Lang, a consultant cardiologist and clinical pharmacologist and Professor of Cardiology and Head of the Division of Molecular and Clinical Medicine at University of Dundee. He trained in both cardiology and clinical pharmacology in the UK and in the USA, where he was a Merck Fellow at Vanderbilt University, Nashville, and a Fulbright Scholar at Columbia University, New York. His patient-oriented research takes a multidisciplinary approach to the understanding of the pathophysiology of heart failure and cardio-metabolic diseases. He leads an integrated cardiovascular research laboratory dedicated to translational research and in the development of biomarkers and novel treatment strategies in patients with cardiovascular diseases. A wide range of funding bodies including the British Heart Foundation, MRC, Chief Scientist Office, Chest Heart and Stroke Scotland, Tenovus and the European Commission (FP-7 and Horizon 2020) funds his research.
Professor Lang has published over 250 papers and has an h-index of 57. He is and has been involved in the editorial boards of several scientific journals including Cardiovascular Therapeutics (Joint Editor-in-Chief), Heart (Associate Editor), Clinical Science(Associate Editor) and Current Clinical Pharmacology. He is Chair of the Heart Failure Working Group of NHS Tayside.
Dr. Jasmine Hau Yuan Wen
Meet Dr. Jasmine Hau Yuan Wen, a research fellow and the head of Cardiac Informatics Cluster at UTM-IJN Cardiovascular Engineering Centre, Universiti Teknologi Malaysia. She is also a senior lecturer at the School of Biomedical Engineering and Health Sciences, Faculty of Engineering, Universiti Teknologi Malaysia. She received both Ph.D. degree and master’s degree in electrical engineering from Universiti Teknologi Malaysia in 2009 and 2005, respectively. Dr. Hau’s research interests are in the design of multi-processor systems-on-chip (MPSoC) /networks-on-chip (NoC), from electronic system level (ESL) modelling to Register Transfer Level (RTL), as well as field programmable gate array (FPGA) implementation. From there her research interests have spread into the field of cryptographic and data security application, biomedical application such as arrhythmia classification and medical imaging processing, as well as ADHD/autism assessment. She has published more than 50 papers in peer reviewed international journals and conferences, and several book chapters. She is also a member of the IEEE.
Ms. Debbie David
Meet Ms. Debbie David, Deputy CEO and Department Head of Patents at Advanz Fidelis IP Sdn Bhd, an award-winning specialist intellectual property corporation in Malaysia. Debbie graduated from the University of Staffordshire with a degree in Computing and thereafter chanced upon the realm of intellectual property, where she has been ever since.
Debbie presently heads the Patent Department at Advanz Fidelis and is actively involved in the full spectrum of patent activities across a wide range of industries. She also consults clients in the identification and development of their IP portfolios and in developing suitable protection and commercialization strategies. She possesses experience across other areas of IP in her 15 years of experience, including advising on collaborations, and working on the development of IP management frameworks, IP education programs and the like.
Debbie is a Registered Patent, Trade Mark, Industrial Designs and Geographical Indications Agent of Malaysia. She is active in both local and international associations and holds committee positions within these associations.
CLINICAL RESEARCH MALAYSIA
D-26-06, Menara Suezcap 1
KL Gateway, No. 2 Jalan Kerinchi
Gerbang Kerinchi Lestari
59200 Kuala Lumpur
Tel: +603 7931 5566
Fax: +603 7931 9940
Disclaimer | Personal Data Protection Act Notice
In The News
- Congratulations Hospital Sultan Abdul Halim for achieving Top Recruiter in APAC!
- Hari Raya 2020 Greeting
- Congratulations to CRM Sponsored Research Award 2020 winners!
- Malaysia an ideal site for new treatment research
- A Tribute to Our Heroes on International Clinical Trials Day
- Establishing Clear Procedures and Improving Start-up Timeline in Malaysia’s Clinical Research Ecosystem
- Recruitment Achievements in Global Sponsored Studies (2018-2019)
6 July |8:00 am - 14 July |6:00 pm UTC+8
20 July |2:00 pm - 4:00 pm UTC+8